Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Aug-24 6:00 PM View:  | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 01-Aug-24 | Option Exercise | 1,507 | $1.74 | $2,622.18 | 12% 12.74K to 14.25K | |
| 02-Aug-24 6:00 PM View: | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 31-Jul-24 | Option Exercise | 11,454 | $1.74 | $19,930.00 | 887% 1.29K to 12.74K | |
| 20-Jun-24 5:56 PM View: | Ra Capital Management, LLC Director 10% Owner | Aerovate Therapeutics, Inc. (AVTE) | 17-Jun-24 | Private Purchase | 928,110 | $1.67 | $1,549,940.00 | 11% 8.26M to 9.19M | |
| 14-Jun-24 6:00 PM View: | Eldridge George A See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 14-Jun-24 | Option Exercise | 15,000 | $2.14 | $32,100.00 | 299% 5.02K to 20.02K | |
| 14-Jun-24 6:00 PM View: | Verwijs Marinus CHIEF TECHNICAL OFFICER | Aerovate Therapeutics, Inc. (AVTE) | 14-Jun-24 | Planned Option Sale | 10,600 | $25.00 | $265,000.00 | (100%) 10.6K to 0 | |
| 14-Jun-24 6:00 PM View: | Eldridge George A See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 14-Jun-24 | Planned Option Sale | 15,000 | $25.03 | $375,450.00 | (75%) 20.02K to 5.02K | |
| 14-Jun-24 6:00 PM View: | Verwijs Marinus CHIEF TECHNICAL OFFICER | Aerovate Therapeutics, Inc. (AVTE) | 14-Jun-24 | Option Exercise | 10,600 | $14.59 | $154,654.00 | 100% 0 to 10.6K | |
| 14-Jun-24 6:00 PM View: | Gillies Hunter Chief Medical Officer | Aerovate Therapeutics, Inc. (AVTE) | 13-Jun-24 | Planned Option Sale | 6,000 | $24.50 | $147,000.00 | (52%) 11.6K to 5.6K | |
| 14-Jun-24 6:00 PM View: | Gillies Hunter Chief Medical Officer | Aerovate Therapeutics, Inc. (AVTE) | 13-Jun-24 | Option Exercise | 6,000 | $2.14 | $12,840.00 | 107% 5.6K to 11.6K | |
| 17-May-24 7:10 PM View: | Gillies Hunter Chief Medical Officer | Aerovate Therapeutics, Inc. (AVTE) | 17-May-24 | Planned Option Sale | 4,000 | $21.08 | $84,331.50 | (42%) 9.6K to 5.6K | |
| 17-May-24 7:10 PM View: | Gillies Hunter Chief Medical Officer | Aerovate Therapeutics, Inc. (AVTE) | 17-May-24 | Option Exercise | 4,000 | $2.14 | $8,560.00 | 71% 5.6K to 9.6K | |
| 17-May-24 7:10 PM View: | Noyes Timothy P Chief Executive Officer Director | Aerovate Therapeutics, Inc. (AVTE) | 16-May-24 | Option Exercise | 10,000 | $2.14 | $21,400.00 | 100% 0 to 10.0K | |
| 17-May-24 7:10 PM View: | Noyes Timothy P Chief Executive Officer Director | Aerovate Therapeutics, Inc. (AVTE) | 16-May-24 | Planned Option Sale | 10,000 | $21.58 | $215,755.00 | (100%) 10.0K to 0 | |
| 03-May-24 6:00 PM View: | Verwijs Marinus CHIEF TECHNICAL OFFICER | Aerovate Therapeutics, Inc. (AVTE) | 02-May-24 | Private Sale | 1,981 | $21.01 | $41,630.70 | (100%) 1.98K to 0 | |
| 03-May-24 6:00 PM View: | Noyes Timothy P Chief Executive Officer Director | Aerovate Therapeutics, Inc. (AVTE) | 01-May-24 | Sale (Planned) | 1,357 | $20.34 | $27,594.70 | (100%) 1.36K to 0 | |
| 03-May-24 6:00 PM View: | Noyes Timothy P Chief Executive Officer Director | Aerovate Therapeutics, Inc. (AVTE) | 01-May-24 | Option Exercise | 10,000 | $2.14 | $21,400.00 | 737% 1.36K to 11.36K | |
| 03-May-24 6:00 PM View: | Noyes Timothy P Chief Executive Officer Director | Aerovate Therapeutics, Inc. (AVTE) | 01-May-24 | Planned Option Sale | 10,000 | $20.34 | $203,351.00 | (88%) 11.36K to 1.36K | |
| 19-Apr-24 6:00 PM View: | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 17-Apr-24 | Planned Option Sale | 6,853 | $22.37 | $153,327.00 | (84%) 8.14K to 1.29K | |
| 19-Apr-24 6:00 PM View: | Gillies Hunter Chief Medical Officer | Aerovate Therapeutics, Inc. (AVTE) | 17-Apr-24 | Planned Option Sale | 4,000 | $22.38 | $89,521.80 | (55%) 7.25K to 3.25K | |
| 19-Apr-24 6:00 PM View: | Gillies Hunter Chief Medical Officer | Aerovate Therapeutics, Inc. (AVTE) | 17-Apr-24 | Option Exercise | 4,000 | $1.74 | $6,960.00 | 123% 3.25K to 7.25K | |
| 19-Apr-24 6:00 PM View: | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 17-Apr-24 | Option Exercise | 6,853 | $2.14 | $14,665.40 | 531% 1.29K to 8.14K | |
| 18-Apr-24 6:00 PM View: | Noyes Timothy P Chief Executive Officer Director | Aerovate Therapeutics, Inc. (AVTE) | 16-Apr-24 | Option Exercise | 10,000 | $2.14 | $21,400.00 | 100% 0 to 10.0K | |
| 18-Apr-24 6:00 PM View: | Noyes Timothy P Chief Executive Officer Director | Aerovate Therapeutics, Inc. (AVTE) | 16-Apr-24 | Planned Option Sale | 10,000 | $24.70 | $246,971.00 | (100%) 10.0K to 0 | |
| 12-Apr-24 6:00 PM View: | Eldridge George A See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 10-Apr-24 | Option Exercise | 7,500 | $2.14 | $16,050.00 | 383% 1.96K to 9.46K | |
| 12-Apr-24 6:00 PM View: | Eldridge George A See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 10-Apr-24 | Planned Option Sale | 7,500 | $26.85 | $201,392.00 | (79%) 9.46K to 1.96K | |
| 11-Apr-24 6:00 PM View: | Grayzel David S. Director | Aerovate Therapeutics, Inc. (AVTE) | 09-Apr-24 | Private Sale | 11,882 | $28.15 | $334,478.00 | (< 1%) 1.81M to 1.8M | |
| 03-Apr-24 6:00 PM View: | Eldridge George A See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 01-Apr-24 | Option Exercise | 12,495 | $2.14 | $26,739.30 | 638% 1.96K to 14.46K | |
| 03-Apr-24 6:00 PM View: | Noyes Timothy P Chief Executive Officer Director | Aerovate Therapeutics, Inc. (AVTE) | 01-Apr-24 | Option Exercise | 10,000 | $2.14 | $21,400.00 | 100% 0 to 10.0K | |
| 03-Apr-24 6:00 PM View: | Noyes Timothy P Chief Executive Officer Director | Aerovate Therapeutics, Inc. (AVTE) | 01-Apr-24 | Planned Option Sale | 10,000 | $30.00 | $300,033.00 | (100%) 10.0K to 0 | |
| 03-Apr-24 6:00 PM View: | Verwijs Marinus CHIEF TECHNICAL OFFICER | Aerovate Therapeutics, Inc. (AVTE) | 01-Apr-24 | Planned Option Sale | 5,300 | $29.19 | $154,697.00 | (100%) 5.3K to 0 | |
| 03-Apr-24 6:00 PM View: | Eldridge George A See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 01-Apr-24 | Planned Option Sale | 12,495 | $31.23 | $390,208.00 | (86%) 14.46K to 1.96K | |
| 03-Apr-24 6:00 PM View: | Verwijs Marinus CHIEF TECHNICAL OFFICER | Aerovate Therapeutics, Inc. (AVTE) | 01-Apr-24 | Option Exercise | 5,300 | $14.59 | $77,327.00 | 100% 0 to 5.3K | |
| 03-Apr-24 6:00 PM View: | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 01-Apr-24 | Option Exercise | 3,325 | $10.61 | $35,278.20 | 258% 1.29K to 4.62K | (5%) |
| 03-Apr-24 6:00 PM View: | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 01-Apr-24 | Planned Private Option Sale | 3,325 | $31.97 | $106,317.00 | (72%) 4.62K to 1.29K | |
| 01-Apr-24 6:00 PM View: | Gillies Hunter Chief Medical Officer | Aerovate Therapeutics, Inc. (AVTE) | 28-Mar-24 | Planned Option Sale | 9,000 | $29.50 | $265,500.00 | (73%) 12.25K to 3.25K | |
| 01-Apr-24 6:00 PM View: | Gillies Hunter Chief Medical Officer | Aerovate Therapeutics, Inc. (AVTE) | 28-Mar-24 | Option Exercise | 9,000 | $2.14 | $19,260.00 | 277% 3.25K to 12.25K | |
| 28-Mar-24 6:00 PM View: | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 27-Mar-24 | Option Exercise | 11,068 | $10.61 | $117,431.00 | 857% 1.29K to 12.36K | (5%) |
| 28-Mar-24 6:00 PM View: | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 27-Mar-24 | Planned Private Option Sale | 11,068 | $27.97 | $309,519.00 | (90%) 12.36K to 1.29K | |
| 27-Mar-24 6:00 PM View: | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 25-Mar-24 | Planned Private Option Sale | 3,432 | $28.01 | $96,119.30 | (73%) 4.72K to 1.29K | |
| 27-Mar-24 6:00 PM View: | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 25-Mar-24 | Option Exercise | 3,432 | $10.61 | $36,413.50 | 266% 1.29K to 4.72K | (5%) |
| 20-Mar-24 6:00 PM View: | Verwijs Marinus CHIEF TECHNICAL OFFICER | Aerovate Therapeutics, Inc. (AVTE) | 19-Mar-24 | Option Exercise | 5,300 | $14.59 | $77,327.00 | 100% 0 to 5.3K | |
| 20-Mar-24 6:00 PM View: | Verwijs Marinus CHIEF TECHNICAL OFFICER | Aerovate Therapeutics, Inc. (AVTE) | 19-Mar-24 | Planned Option Sale | 5,300 | $26.08 | $138,243.00 | (100%) 5.3K to 0 | |
| 20-Mar-24 6:00 PM View: | Gillies Hunter Chief Medical Officer | Aerovate Therapeutics, Inc. (AVTE) | 18-Mar-24 | Planned Option Sale | 7,000 | $25.87 | $181,057.00 | (68%) 10.25K to 3.25K | |
| 20-Mar-24 6:00 PM View: | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 18-Mar-24 | Option Exercise | 35,057 | $5.64 | $197,837.00 | 2715% 1.29K to 36.35K | |
| 20-Mar-24 6:00 PM View: | Gillies Hunter Chief Medical Officer | Aerovate Therapeutics, Inc. (AVTE) | 18-Mar-24 | Option Exercise | 7,000 | $1.91 | $13,380.00 | 215% 3.25K to 10.25K | |
| 20-Mar-24 6:00 PM View: | Dake Benjamin T See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 18-Mar-24 | Planned Option Sale | 35,057 | $25.90 | $908,046.00 | (96%) 36.35K to 1.29K | |
| 14-Mar-24 6:00 PM View: | Eldridge George A See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 13-Mar-24 | Planned Option Sale | 2,016 | $25.02 | $50,445.00 | (51%) 3.98K to 1.96K | |
| 14-Mar-24 6:00 PM View: | Eldridge George A See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 13-Mar-24 | Option Exercise | 2,016 | $2.14 | $4,314.24 | 103% 1.96K to 3.98K | |
| 14-Mar-24 6:00 PM View: | Eldridge George A See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 12-Mar-24 | Option Exercise | 2,051 | $2.14 | $4,389.14 | 105% 1.96K to 4.01K | |
| 14-Mar-24 6:00 PM View: | Eldridge George A See Remarks | Aerovate Therapeutics, Inc. (AVTE) | 12-Mar-24 | Planned Option Sale | 2,051 | $25.05 | $51,369.60 | (51%) 4.01K to 1.96K |
